GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,591,000 | -52.2% | 874,144 | -26.7% | 0.53% | -24.0% |
| Q3 2021 | $3,329,000 | -10.3% | 1,193,100 | -2.3% | 0.70% | -49.1% |
| Q2 2021 | $3,711,000 | -29.1% | 1,220,794 | -19.9% | 1.38% | -23.1% |
| Q1 2021 | $5,231,000 | +10.3% | 1,525,000 | 0.0% | 1.80% | -5.1% |
| Q4 2020 | $4,743,000 | -11.3% | 1,525,000 | +0.7% | 1.89% | -32.8% |
| Q3 2020 | $5,348,000 | +13.6% | 1,515,000 | +53.8% | 2.82% | +25.9% |
| Q2 2020 | $4,708,000 | +41.0% | 985,000 | +2.1% | 2.24% | -33.6% |
| Q1 2020 | $3,339,000 | -79.8% | 965,000 | -66.3% | 3.36% | +3167.0% |
| Q4 2019 | $16,569,000 | +263.0% | 2,866,404 | +200.1% | 0.10% | -64.2% |
| Q3 2019 | $4,565,000 | -23.1% | 955,105 | +18.3% | 0.29% | -40.6% |
| Q2 2019 | $5,934,000 | +10.1% | 807,400 | +22.4% | 0.48% | +1.0% |
| Q1 2019 | $5,388,000 | +57.8% | 659,526 | +31.9% | 0.48% | -13.7% |
| Q4 2018 | $3,415,000 | -39.8% | 500,000 | +19.6% | 0.56% | -82.4% |
| Q3 2018 | $5,676,000 | +40.7% | 418,000 | +23.3% | 3.15% | +37.7% |
| Q2 2018 | $4,034,000 | +189.4% | 339,000 | +35.5% | 2.29% | +99.3% |
| Q1 2018 | $1,394,000 | -32.9% | 250,200 | +10.2% | 1.15% | -4.7% |
| Q4 2017 | $2,077,000 | – | 227,000 | – | 1.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|